BRIX1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.766000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.877240E-01
Normal-vs-Stage2
3.005200E-01
Normal-vs-Stage3
7.173400E-01
Normal-vs-Stage4
5.147600E-02
Stage1-vs-Stage2
9.654800E-01
Stage1-vs-Stage3
5.461400E-01
Stage1-vs-Stage4
2.812400E-01
Stage2-vs-Stage3
4.957200E-01
Stage2-vs-Stage4
4.033200E-01
Stage3-vs-Stage4
2.497000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.815400E-01
Normal-vs-AfricanAmerican
4.218200E-01
Normal-vs-Asian
2.298600E-01
Caucasian-vs-AfricanAmerican
9.292800E-01
Caucasian-vs-Asian
8.789000E-01
AfricanAmerican-vs-Asian
8.648400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.462600E-01
Normal-vs-Female
3.023800E-01
Male-vs-Female
5.638400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.110600E-01
Normal-vs-Age(41-60Yrs)
2.038000E-01
Normal-vs-Age(61-80Yrs)
3.387600E-01
Normal-vs-Age(81-100Yrs)
2.100400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.533600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.572400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.200600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.786400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.254400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.176800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.147600E-01
Normal-vs-Daily Drinker
2.243800E-01
Normal-vs-Weekly Drinker
3.395200E-01
Normal-vs-Occasional Drinker
7.394200E-02
Normal-vs-Social Drinker
2.410200E-01
Non Drinker-vs-Daily Drinker
3.404000E-01
Non Drinker-vs-Weekly Drinker
2.439400E-01
Non Drinker-vs-Occasional Drinker
5.346200E-02
Non Drinker-vs-Social Drinker
6.718800E-01
Daily Drinker-vs-Weekly Drinker
5.144200E-01
Daily Drinker-vs-Occasional Drinker
2.724200E-01
Daily Drinker-vs-Social Drinker
6.207400E-01
Weekly Drinker-vs-Occasional Drinker
9.771200E-01
Weekly Drinker-vs-Social Drinker
3.537400E-01
Occasional Drinker-vs-Social Drinker
1.168600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.309000E-01
Normal-vs-Grade 2
7.588000E-01
Normal-vs-Grade 3
7.859800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.580200E-01
Grade 1-vs-Grade 3
9.894200E-02
Grade 1-vs-Grade 4
7.309000E-01
Grade 2-vs-Grade 3
2.838400E-01
Grade 2-vs-Grade 4
7.588000E-01
Grade 3-vs-Grade 4
7.859800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.747400E-01
Normal-vs-NonDiabetic
2.591000E-01
Diabetic-vs-NonDiabetic
1.682370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.608600E-01
Normal-vs-NoPancreatitis
3.097000E-01
Pancreatitis-vs-NoPancreatitis
9.371600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.494590E-01
Normal-vs-N1
3.206800E-01
N0-vs-N1
8.246400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.618300E-02
Normal-vs-TP53-NonMutant
2.502000E-01
TP53-Mutant-vs-TP53-NonMutant
2.158400E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
